Studies

  1. The gut microbiota in IBD

  2. Gut virome in inflammatory bowel disease and beyond

  3. Preclinical Serological Signatures are Associated With Complicated CD at Diagnosis

  4. Gut microbiota signatures in inflammatory bowel disease

  5. From ASCA breakthrough in Crohn’s disease and Candida albicans research to thirty years of investigations about their meaning in human health

  6. Human enteric viruses autonomously shape inflammatory bowel disease phenotype through divergent innate immunomodulation

  7. Selection of cross-reactive T cells by commensal and food-derived yeasts drives cytotoxic T~H~1 cell responses in Crohn’s disease

  8. Gut virome-colonising *Orthohepadnavirus* genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation *in vivo*

  9. *Enterobacteriaceae* Growth Promotion by Intestinal Acylcarnitines, a Biomarker of Dysbiosis in Inflammatory Bowel Disease

  10. Appendectomy and Tonsillectomy in Patients with Inflammatory Bowel Disease